27 related articles for article (PubMed ID: 38530787)
1. Fisetin inhibits human melanoma cell invasion through promotion of mesenchymal to epithelial transition and by targeting MAPK and NFκB signaling pathways.
Pal HC; Sharma S; Strickland LR; Katiyar SK; Ballestas ME; Athar M; Elmets CA; Afaq F
PLoS One; 2014; 9(1):e86338. PubMed ID: 24466036
[TBL] [Abstract][Full Text] [Related]
2. Dermokine-β impairs ERK signaling through direct binding to GRP78.
Higashi K; Hasegawa M; Yokoyama C; Tachibana T; Mitsui S; Saito K
FEBS Lett; 2012 Jul; 586(16):2300-5. PubMed ID: 22735594
[TBL] [Abstract][Full Text] [Related]
3. The A
Giacomelli C; Daniele S; Romei C; Tavanti L; Neri T; Piano I; Celi A; Martini C; Trincavelli ML
Front Pharmacol; 2018; 9():54. PubMed ID: 29445342
[TBL] [Abstract][Full Text] [Related]
4. PI3K/AKT signaling allows for MAPK/ERK pathway independency mediating dedifferentiation-driven treatment resistance in melanoma.
Corrales E; Levit-Zerdoun E; Metzger P; Mertes R; Lehmann A; Münch J; Lemke S; Kowar S; Boerries M
Cell Commun Signal; 2022 Nov; 20(1):187. PubMed ID: 36434616
[TBL] [Abstract][Full Text] [Related]
5. Dermokine mutations contribute to epithelial-mesenchymal transition and advanced melanoma through ERK/MAPK pathways.
Ma W; Wu Z; Maghsoudloo M; Ijaz I; Dehghan Shasaltaneh M; Zhang Y; Weng Q; Fu J; Imani S; Wen QL
PLoS One; 2023; 18(7):e0285806. PubMed ID: 37432950
[TBL] [Abstract][Full Text] [Related]
6. CCDC88A Post-Transcriptionally Regulates VEGF
Hu Q; Li Y; Chen H; Liao H; He Y; Zheng Q
Front Immunol; 2022; 13():859331. PubMed ID: 35493459
[TBL] [Abstract][Full Text] [Related]
7. Retraction: Dermokine mutations contribute to epithelial-mesenchymal transition and advanced melanoma through ERK/MAPK pathways.
PLOS ONE Editors
PLoS One; 2024; 19(3):e0300807. PubMed ID: 38530787
[No Abstract] [Full Text] [Related]
8. Potential therapeutic targets of epithelial-mesenchymal transition in melanoma.
Pearlman RL; Montes de Oca MK; Pal HC; Afaq F
Cancer Lett; 2017 Apr; 391():125-140. PubMed ID: 28131904
[TBL] [Abstract][Full Text] [Related]
9. Extracellular-Signal Regulated Kinase: A Central Molecule Driving Epithelial-Mesenchymal Transition in Cancer.
Olea-Flores M; Zuñiga-Eulogio MD; Mendoza-Catalán MA; Rodríguez-Ruiz HA; Castañeda-Saucedo E; Ortuño-Pineda C; Padilla-Benavides T; Navarro-Tito N
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31200510
[TBL] [Abstract][Full Text] [Related]
10. Melanoma: molecular pathogenesis and emerging target therapies (Review).
Russo AE; Torrisi E; Bevelacqua Y; Perrotta R; Libra M; McCubrey JA; Spandidos DA; Stivala F; Malaponte G
Int J Oncol; 2009 Jun; 34(6):1481-9. PubMed ID: 19424565
[TBL] [Abstract][Full Text] [Related]
11. Extracellular-signal-regulated kinase/mitogen-activated protein kinase signaling as a target for cancer therapy: an updated review.
Najafi M; Ahmadi A; Mortezaee K
Cell Biol Int; 2019 Nov; 43(11):1206-1222. PubMed ID: 31136035
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
